EP 4171532 A1 20230503 - A STABLE COMBINATION OF VILDAGLIPTIN AND METFORMIN HCI
Title (en)
A STABLE COMBINATION OF VILDAGLIPTIN AND METFORMIN HCI
Title (de)
STABILE KOMBINATION VON VILDAGLIPTIN UND METFORMIN HCI
Title (fr)
COMBINAISON STABLE DE VILDAGLIPTINE ET DE METFORMINE HCI
Publication
Application
Priority
- TR 202009946 A 20200625
- TR 2021050442 W 20210507
Abstract (en)
[origin: WO2021262115A1] The present invention relates to a tablet formulation comprising vildagliptin and metformin hydrochloride wherein vildagliptin and at least one acidifying agent is dissolved in a solvent. The present invention also relates to a simple, rapid, cost effective, time-saving and industrially convenient process.
IPC 8 full level
A61K 31/155 (2006.01); A61K 9/20 (2006.01); A61K 31/40 (2006.01)
CPC (source: EP)
A61K 9/2009 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 31/155 (2013.01); A61K 31/40 (2013.01)
C-Set (source: EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021262115 A1 20211230; EP 4171532 A1 20230503; TR 202009946 A2 20220121
DOCDB simple family (application)
TR 2021050442 W 20210507; EP 21828954 A 20210507; TR 202009946 A 20200625